Panacea Innovation Ltd - 31 Dec 2024 SCHEDULE 13G/A Report for Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX)

Filing Manager: Panacea Innovation Ltd
Reporting Manager: Panacea Venture Healthcare Fund II, L.P.
Security: Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol: AMLX
Shares outstanding: 84,615,385 shares
Disclosed Ownership: 2,200,000 shares
Ownership: 2.6%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:30:03 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Quoteable Key Fact

"Panacea Innovation Ltd disclosed 2.6% ownership in Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX) on 31 Dec 2024."

Quick Takeaways

Panacea Innovation Ltd filed SCHEDULE 13G/A for Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX).
Disclosed ownership: 2.6%.
Date of event: 31 Dec 2024.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Panacea Venture Healthcare Fund II, L.P.	2.6%	2,200,000	2,200,000	By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang	James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd.	2.6%	2,200,000	2,200,000	By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang	James Huang, Founding Managing Partner
Panacea Innovation Limited	2.6%	2,200,000	2,200,000	/s/ James Huang	James Huang, Founding Managing Partner
James Huang	2.6%	2,200,000	2,200,000	/s/ James Huang	James Huang